Morgan Stanley (MS) Dividend Safety Gauge & 10-Year DRIP Compounder

Per the Roarable RQD rating, MS scores 40 out of 100 with a letter grade of D-, labeled "Roarable Sell — Vulnerable Balance Sheet & Flow." The five pillars are:

• Fundamental Cash Engine: 4 / 20 (ROIC 3%; FCF yield -7.25%). This is the weakest pillar and indicates that, per the market data section, the company's return on invested capital and free cash flow yield are both poor relative to the market price.
• Whale 13F Flow: 11 / 20 (institutional accumulation and options positioning). A middling score; the source does not provide the underlying 13F detail, so the composition of this signal cannot be verified here.
• Insider Conviction: 8 / 20 (SEC Form 4 and Congressional PTR cluster flow). A below-average score; the underlying trade records are not included in the source data.
• Macro Regime Fit: 4 / 20 (Beta 1.04; sector sensitivity). Beta of 1.04 implies the stock moves roughly in line with the market, and the low pillar score signals weak alignment with the current regime per the RQD methodology.
• Forensic Balance Sheet: 13 / 20 (Altman Z 2.5; Piotroski F 5/9; Debt/Equity 0.5). The strongest pillar, though still moderate.

For a prospective investor, the rating highlights a tension: the stock trades at a P/E (TTM) of 17.7 and forward P/E of 16.5, which may look reasonable on earnings, but the cash-flow and return-on-capital measures per the RQD rating are weak. Upside drivers would need to come from improved free cash flow conversion or higher returns on invested capital; the valuation tradeoff is that earnings multiples do not reflect the negative FCF yield. Investors should weigh the earnings-based valuation against the cash-based warning signals.

Per the SEC financials, operating income and net income rose across the three reported periods, while free cash flow was negative in FY 2025 and FY 2023 and positive in FY 2024. Debt increased from $38405.1M (FY 2023) to $588428.1M (FY 2025). The Roarable RQD rating cites an Altman Z-Score of 2.5, a Piotroski F-Score of 5/9, and a Debt/Equity ratio of 0.5 as forensic balance-sheet measures. Gross margin is reported as 0% in the market data, which is not consistent with a revenue figure of $0.0M and should be treated as unreliable. ROIC is 3% per the market data.

• What drives the $0.0M revenue figure alongside reported operating and net income, and how does the company classify its top line?
• What explains the swing from negative free cash flow in FY 2025 to positive in FY 2024, and what is the underlying cash conversion trend?
• What is the composition and timing of the debt increase from $38405.1M (FY 2023) to $588428.1M (FY 2025)?
• What are the underlying 13F, Form 4, and Congressional trade records behind the whale-flow and insider-conviction pillar scores?
• Why is the reported gross margin 0% and how does it reconcile with the other margin figures?